{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:44:28Z","timestamp":1760147068456,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research Program of Beijing Education Commission, P. R. China","award":["KM201810005031"],"award-info":[{"award-number":["KM201810005031"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>As a tumor-targeting oncolytic adenovirus (Ad), conditionally replicating adenovirus (CRAd) can access the cell interior by binding to coxsackievirus-Ad receptors (CARs) and specifically replicate and destroy cancer cells without lethal effects on normal cells. The transduction efficiency of CRAd is highly dependent on the number of CARs on the cell membrane. However, not all tumor cells highly express CARs; therefore, improving the transduction efficiency of CRAd is beneficial for improving its antitumor effect. In this study, 6-cyclohexyl methyl-\u03b2-D-maltoside (6-\u03b2-D), as maltoside transfection agent, showed several advantages, including high transfection efficiency, low toxicity, and potential for intensive use and easy operation. With pretreatment of cancer cells with low concentration of 6-\u03b2-D (\u22645 \u03bcg\/mL), the transduction efficiency of \u201cmodel\u201d Ad (eGFP-Ad) was improved 18-fold compared to eGFP-Ad alone. 6-\u03b2-D improved the antitumor effect of CRAd while being safe for normal cells, in which treatment with 6-\u03b2-D helped the lethal effects of CRAd at a multiplicity-of-infection ratio of 10 (MOI 10) achieve the oncolytic outcomes of MOI 50. This means that if CRAd is combined with 6-\u03b2-D, the amount of CRAd used in clinical practice could be greatly reduced without diminishing its curative effect or exposing patients to the potential side effects of high-titer CRAd. Finally, the underlying mechanism of antitumor effect of CRAd + 6-\u03b2-D was primarily investigated, and we found that 6-\u03b2-D increased the virus\u2019s replication in cancer cells at the early stage of infection and activated the apoptosis signaling pathway at the late stage of the cell cycle. This research will provide an effective technical reference for further improving Ad-mediated cancer gene therapy in clinical practice.<\/jats:p>","DOI":"10.3390\/molecules28020528","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:29:48Z","timestamp":1672896588000},"page":"528","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving the Transduction Efficiency and Antitumor Effect of Conditionally Replicative Adenovirus by Application of 6-cyclohexyl Methyl-\u03b2-D-maltoside"],"prefix":"10.3390","volume":"28","author":[{"given":"Wenjing","family":"Lu","sequence":"first","affiliation":[{"name":"Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Fang","sequence":"additional","affiliation":[{"name":"Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Meng","sequence":"additional","affiliation":[{"name":"Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdong","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing International Science and Technology Cooperation Base of Antivirus Drug, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41417-020-00227-y","article-title":"Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer","volume":"28","author":"Goedegebuure","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"120375","DOI":"10.1016\/j.lfs.2022.120375","article-title":"Gene therapy: Comprehensive overview and therapeutic applications","volume":"294","author":"Sayed","year":"2022","journal-title":"Life Sci."},{"doi-asserted-by":"crossref","unstructured":"Watanabe, M., Nishikawaji, Y., Kawakami, H., and Kosai, K.-I. (2021). Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy. Viruses, 13.","key":"ref_4","DOI":"10.3390\/v13122502"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13287-019-1268-z","article-title":"Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer","volume":"10","author":"Muhammad","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/s41598-020-61275-w","article-title":"Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis","volume":"10","author":"Sasso","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.cgt.7700752","article-title":"Cancer-specific activation of the survivin promoter and its potential use in gene therapy","volume":"11","author":"Chen","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ctrv.2009.05.003","article-title":"Survivin: A new target for anti-cancer therapy","volume":"35","author":"Ryan","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41417-019-0145-3","article-title":"ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma","volume":"27","author":"Mu","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.cgt.7700284","article-title":"Coxsackievirus\u2013adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression","volume":"8","author":"You","year":"2001","journal-title":"Cancer Gene Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/gyno.2002.6607","article-title":"Enhancement of the Adenoviral Sensitivity of Human Ovarian Cancer Cells by Transient Expression of Coxsackievirus and Adenovirus Receptor (CAR)","volume":"85","author":"Kim","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.21873\/anticanres.15164","article-title":"Cancer Cell-specific Transfection of hCas9 Gene Using Ad5F35 Vector","volume":"41","author":"Matsunaga","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"112185","DOI":"10.1016\/j.yexcr.2020.112185","article-title":"Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells","volume":"396","author":"Cui","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/CAD.0000000000000854","article-title":"A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro","volume":"31","author":"Tian","year":"2020","journal-title":"Anti-Cancer Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.actbio.2020.11.003","article-title":"Gene transfection achieved by utilizing antibacterial calcium phosphate nanoparticles for enhanced regenerative therapy","volume":"119","author":"Xiang","year":"2021","journal-title":"Acta Biomater."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1002\/chem.202005257","article-title":"Biological and Medical Applications of Calcium Phosphate Nanoparticles","volume":"27","author":"Sokolova","year":"2021","journal-title":"Chemistry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2007421","DOI":"10.1002\/adma.202007421","article-title":"Materials for Improving Immune Cell Transfection","volume":"33","author":"Kumar","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120966","DOI":"10.1016\/j.biomaterials.2021.120966","article-title":"Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles","volume":"275","author":"Kaczmarek","year":"2021","journal-title":"Biomaterials"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"22955","DOI":"10.1021\/acsomega.1c03620","article-title":"Gemini Lipopeptide Bearing an Ultrashort Peptide for Enhanced Transfection Efficiency and Cancer-Cell-Specific Cytotoxicity","volume":"6","author":"Ravula","year":"2021","journal-title":"ACS Omega"},{"doi-asserted-by":"crossref","unstructured":"Stetsenko, A., and Guskov, A. (2017). An Overview of the Top Ten Detergents Used for Membrane Protein Crystallization. Crystals, 7.","key":"ref_20","DOI":"10.3390\/cryst7070197"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1021\/acs.langmuir.0c03214","article-title":"Maltose-Based Fluorinated Surfactants for Membrane-Protein Extraction and Stabilization","volume":"37","author":"Wehbie","year":"2021","journal-title":"Langmuir"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.bbamem.2008.05.017","article-title":"Heterologous expression of human Neuromedin U receptor 1 and its subsequent solubilization and purification","volume":"1778","author":"Xia","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.21873\/anticanres.14829","article-title":"Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing Activity","volume":"41","author":"Sakurai","year":"2021","journal-title":"Anticancer Res."},{"doi-asserted-by":"crossref","unstructured":"Brachtlova, T., and Van Beusechem, V.W. (2018). Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens. Cells, 7.","key":"ref_24","DOI":"10.3390\/cells7120228"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.7150\/thno.42869","article-title":"SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lfs.2018.03.020","article-title":"Melatonin resists oxidative stress-induced apoptosis in nucleus pulposus cells","volume":"199","author":"He","year":"2018","journal-title":"Life Sci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/2\/528\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:59:56Z","timestamp":1760119196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/2\/528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["molecules28020528"],"URL":"https:\/\/doi.org\/10.3390\/molecules28020528","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2023,1,5]]}}}